We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Trulance

News List

Salix Will Share TRULANCE® (Plecanatide) Data At The 2021 AANP National Conference prnewswire
June 16, 2021
Salix Pharmaceuticals ("Salix"),announced today that data featuring TRULANCE® (plecanatide) will be shared at the American Association of Nurse Practitioners' (AANP) 2021 AANP National Conference, which takes place virtually June 15 through Aug. 31, 2021.
Synergy Pharmaceuticals inks deal with Luxion Pharma biospectrumasia
August 13, 2018
The deal gives Luoxin exclusive rights to develop and commercialize Synergy’s lead product TRULANCE (plecanatide) for the treatment of adults with chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C) in mainland Chi
Express Scripts hobbles new Synergy med Trulance with Allergan-favoring formulary maneuver fiercepharma
August 03, 2017
Earlier this year, Allergan’s Linzess and Takeda’s Amitiza gained a new competitor in Synergy’s Trulance. But just as the newcomer was settling into challenge mode, Express Scripts has dealt it a serious blow.
FDA Approves Trulance for Chronic Idiopathic Constipation americanpharmaceuticalreview
January 22, 2017
The U.S. Food and Drug Administration has approved Trulance (plecanatide) for the treatment of Chronic Idiopathic Constipation (CIC) in adult patients.